Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods

Current Problems in Diagnostic Radiology

Volumn 44, Issue 6, 2015, Pages 501-504

  Nicola, Refky ^a   Shaqdan, Khalid W ^b   Aran, Khalid ^b   Mansouri, Mohammad ^b   Singh, Ajay ^b   Abujudeh, Hani H ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; IODINATED CONTRAST MEDIUM; METFORMIN; CONTRAST MEDIUM;

CONTRAST INDUCED NEPHROPATHY; FLUID THERAPY; HEMODIALYSIS PATIENT; HUMAN; MANAGED CARE; PATHOGENESIS; PATIENT SAFETY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; RISK FACTORS;

EID: 84940956908     PISSN: 03630188     EISSN: 15356302     Source Type: Journal    
DOI: 10.1067/j.cpradiol.2015.04.002     Document Type: Review

References (40)

1. Hou S.H., Bushinsky D.A., Wish J.B., et al. Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983, 74:243-248.
2. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. A J Kidney Dis 2002, 39:930-936.
3. McCullough P.A., Wolyn R., Rocher L.L., et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997, 103:368-375.
4. Hoste E.A., Doom S., De Waele J., et al. Epidemiology of contrast-associated acute kidney injury in ICU patients: A retrospective cohort analysis. Intensive Care Med 2011, 37:1921-1931.
5. Waybill M.M., Waybill P.N. Contrast media-induced nephrotoxicity: Identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001, 12:3-9.
6. Owen R.J., Hiremath S., Myers A., et al. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: Update 2012. Can Assoc Radiol J 2014, 65:96-105.
7. Pannu N., Wiebe N., Tonelli M., et al. Prophylaxis strategies for contrast-induced nephropathy. J Am Med Assoc 2006, 295:2765-2779.
8. Dirkes S. Acute kidney injury: Not just acute renal failure anymore?. Crit Care Nurse 2011, 31:37-49. [quiz 50].
9. Thomsen H.S., Bush W.H. Adverse effects of contrast media: Incidence, prevention and management. Drug Saf 1998, 19:313-324.
10. Morcos S.K., Thomsen H.S. Adverse reactions to iodinated contrast media. Eur Radiol 2001, 11:1267-1275.
11. McDonald R.J., McDonald J.S., Bida J.P., et al. Intravenous contrast material-induced nephropathy: Causal or coincident phenomenon?. Radiology 2013, 267:106-118.
12. McDonald J.S., McDonald R.J., Comin J., et al. Frequency of acute kidney injury following intravenous contrast medium administration: A systematic review and meta-analysis. Radiology 2013, 267:119-128.
13. Newhouse J.H., Kho D., Rao Q.A., et al. Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity. Am J Roentgenol 2008, 191:376-382.
14. Cramer B.C., Parfrey P.S., Hutchinson T.A., et al. Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med 1985, 145:87-89.
15. Heller C.A., Knapp J., Halliday J., et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991, 155:329-332.
16. Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 1995, 47:254-261.
17. Wong P.C., Li Z., Guo J., et al. Pathophysiology of contrast-induced nephropathy. Int J Cardiol 2012, 158:186-192.
18. Manske C.L., Sprafka J.M., Strony J.T., et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990, 89:615-620.
19. Tepel M., Aspelin P., Lameire N. Contrast-induced nephropathy: A clinical and evidence-based approach. Circulation 2006, 113:1799-1806.
20. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004, 44:1393-1399.
21. Persson P.B., Hansell P., Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005, 68:14-22.
22. Weisbord S.D., Palevsky P.M. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008, 3:273-280.
23. Pattharanitima P., Tasanarong A. Pharmacological strategies to prevent contrast-induced acute kidney injury. BioMed Res Int 2014, 2014:236930.
24. Briguori C., Tavano D., Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis 2003, 45:493-503.
25. Stevens M.A., McCullough P.A., Tobin K.J., et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study. J Am Coll Cardiol 1999, 33:403-411.
26. McCullough P.A., Soman S.S. Contrast-induced nephropathy. Crit Care Clin 2005, 21:261-280.
27. Brar S.S., Shen A.Y., Jorgensen M.B., et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. J Am Med Assoc 2008, 300:1038-1046.
28. Gupta R.K., Bang T.J. Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice. Semin Intervent Radiol 2010, 27:348-359.
29. Vasheghani-Farahani A., Sadigh G., Kassaian S.E., et al. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: A randomized controlled trial. American J Kidney Dis 2009, 54:610-618.
30. Klima T., Christ A., Marana I., et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: A randomized controlled trial. Eur Heart J 2012, 33:2071-2079.
31. Zhang B., Liang L., Chen W., et al. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: A meta-analysis. Br Med J open 2015, 5:e006989.
32. Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006, 354:2773-2782.
33. Sun Z., Fu Q., Cao L., et al. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: A meta-analysis of randomized, controlled trials. PloS One 2013, 8:e55124.
34. Stacul F., Adam A., Becker C.R., et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006, 98:59K-77K.
35. Kwok C.S., Pang C.L., Yeong J.K., et al. Measures used to treat contrast-induced nephropathy: Overview of reviews. Br J Radiol 2013, 86:20120272.
36. Kiski D., Stepper W., Brand E., et al. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: A post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 2010, 25:759-764.
37. Marenzi G. Prevention of contrast-induced nephropathy and management of high-risk patients. G Ital Cardiol 2009, 10:88-96.
38. Bailey C.J. Biguanides and NIDDM. Diabetes Care 1992, 15:755-772.
39. Schweiger M.J., Chambers C.E., Davidson C.J., et al. Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007, 69:135-140.
40. Rao Q.A., Newhouse J.H. Risk of nephropathy after intravenous administration of contrast material: A critical literature analysis. Radiology 2006, 239:392-397.